NSE - Delayed Quote INR

EMCURE PHARMACEUTICALS L (EMCURE.NS)

1,325.90
-1.50
(-0.11%)
At close: 3:29:59 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 21.16B
Earnings 1.97B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
15B
20B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,350.00
1,458.33 Average
1,325.90 Current
1,625.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
No. of Analysts ----33
Avg. Estimate 0049.559.11
Low Estimate 0049.558.2
High Estimate 0050.5560.94
Year Ago EPS ----36.8349.5

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
No. of Analysts ----33
Avg. Estimate ----89.19B98.94B
Low Estimate ----89.19B98.94B
High Estimate ----89.19B99.42B
Year Ago Sales ----78.96B89.19B
Sales Growth (year/est) ----12.96%10.92%

Earnings History

Currency in INR 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. --8.89.610.1
EPS Actual 7.9510.338.1210.38
Difference --1.53-1.480.28
Surprise % --17.39%-15.42%2.82%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
Current Estimate 0049.558.2
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
Up Last 7 Days ----33
Up Last 30 Days ----33
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
EMCURE.NS ----34.39%19.42%
S&P 500 13.13%2.46%7.55%14.08%

Related Tickers